Get the latest news, insights, and market updates on all tickers. Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Allogene Therapeutics Teases April ALPHA3 Data as cema-cel Targets MRD+ LBCL in Remission
Allogene Therapeutics (NASDAQ:ALLO) Chief Medical Officer Zach Roberts said the company expects to report initial data in April from its ALPHA3 study, a frontline consolidation trial evaluating its off-the-shelf allogeneic CD19 CAR T-cell therapy, cema-cel, in large B-cell lymphoma (LBCL). Roberts d Feb 19, 2026 - $ALLO
Analysts Trim Alnylam Pharmaceuticals, Inc. (ALNY) Targets but Keep Faith in 2026 Growth
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is among the best money-making stocks to buy right now. On February 13, Morgan Stanley trimmed the price target on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) to $360 from $408 and reiterated an Equal Weight rating, TheFly reported. In a research note, the analyst said that although near-term pressures exist, the preannounced fourth-quarter […] Feb 19, 2026 - $ALNY
How Investors May Respond To AMC (AMC) Equity Shelf Plans And Debt Refinancing Efforts
Earlier this month, AMC Entertainment Holdings filed an omnibus shelf registration covering common and preferred stock, subscription rights, depositary shares, warrants and units, and also registered an at-the-market follow-on common equity offering of up to US$150 million. These moves sit alongside AMC’s efforts to refinance about US$2.50 billion of debt and fund US$1.50 billion of theater upgrades, underscoring how capital-raising and balance sheet repair are central to its current... Feb 19, 2026 - $AMC
Tata partners with OpenAI to build India's first major AI data center
<body><p>STORY: :: New Delhi, India / February 19, 2026</p><p>:: Tata Group announces a deal with OpenAI to create India's first major AI-optimized data center</p><p>:: Natarajan Chandrasekaran, Chairman of Tata Group</p><p>“The Tata Group is establishing India's first large-scale AI-optimized data center purpose-built for the next generation AI training on inference. I'm very happy to announce that we have partnered with OpenAI to build the first 100 megawatt capacity, which will scale to one gigawatt.”</p><p>:: Chandrasekaran said Tata would also work with AMD to create 'high density AI capacity in India'</p><p>“And we made an announcement with AMD yesterday, where we will combine the world class AI rack architecture with Tata's strength in infrastructure, engineering, power and solution capabilities to create a sustainable, high density AI capacity in India for global standards.”</p><p>Speaking at the AI Impact Summit on Thursday, Tata Group Chairman Natarajan Chandrasekaran said the facility would begin with 100 megawatts of capacity, expandable to one gigawatt.</p><p>The deal is a major boost for Tata Group's Tata Consultancy Services (TCS), which had last year disclosed plans to invest up to $7 billion in a 1 gigawatt data center unit in India.</p><p>The AI Impact Summit is being billed as the first major artificial intelligence forum in the Global South, where India has sought to position itself as a leading voice in global AI governance.</p></body> Feb 19, 2026 - $AMD
End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations
Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the 13 hot stocks to buy with the highest upside potential. On February 2, Jefferies lowered its price target on Apogee Therapeutics Inc. (NASDAQ:APGE) to $95 from $98 while keeping its Buy rating on the stock. The analyst also reduced its risk-adjusted peak sales forecast for Apogee’s ’279 […] Feb 19, 2026 - $AMGN
Amgen Details Oncology R&D Push, IMDELLTRA Expansion and LUMAKRAS Updates at Citi Summit
Amgen (NASDAQ:AMGN) executives outlined the company’s oncology research and development priorities and provided updates on several key programs during Citi’s Virtual Oncology Leadership Summit. Jean-Charles Soria, senior vice president of global development in oncology, said Amgen’s framework emphas Feb 19, 2026 - $AMGN
Amplitude Q4 Earnings Call Highlights
Amplitude (NASDAQ:AMPL) reported what management called “one of the strongest quarters” in company history as fourth-quarter revenue and annual recurring revenue both rose 17% year over year, supported by enterprise traction, multi-product adoption, and increasing use of AI-driven workflows. Quarte Feb 19, 2026 - $AMPL
Amprius Technologies (AMPX) Is Down 10.8% After New U.S. Defense-Focused Battery Manufacturing Partnership Announced – Has The Bull Case Changed?
In recent days, Nanotech Energy announced a manufacturing partnership with Amprius Technologies to create a U.S.-based production pathway for Amprius’ high-performance silicon battery cells, aimed at meeting stringent defense-sector requirements for quality, security, and performance. At the same time, new analyst coverage framed Amprius as an important supplier to unmanned aerial systems, highlighting how defense and drone applications are shaping demand for its advanced batteries. We’ll... Feb 19, 2026 - $AMPX
Needham Initiates Amprius Technologies (AMPX) as Key Pure-Play Unmanned Aerial Systems Supplier
Amprius Technologies Inc. (NYSE:AMPX) is one of the best single digit stocks to buy according to analysts. On January 29, Needham initiated coverage of Amprius Technologies with a Buy rating and a $20 price target. This firm identified the company as a premier pure-play supplier in an emerging global market for unmanned aerial systems. The […] Feb 19, 2026 - $AMPX
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple